Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p

References

• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64–80.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Wu L, Li C, Pan L. Nasopharyngeal carcinoma: a review of current updates. Exp Ther Med. 2018;15:3687–3692.
   PubMed Web of Science ®Google Scholar
• Wei KR, Zheng RS, Zhang SW, et al. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36:90.
   PubMedGoogle Scholar
• Razak AR, Siu LL, Liu FF, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46:1967–1978.
   PubMed Web of Science ®Google Scholar
• Perri F, Dell’Oca I, Muto P, et al. Optimal management of a patient with recurrent nasopharyngeal carcinoma. World J Clin Cases. 2014;2:297–300.
   PubMed Web of Science ®Google Scholar
• Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31:4577–4587.
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904–914.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393–407.
   PubMed Web of Science ®Google Scholar
• Tang Y, He X. Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications. Mol Cell Biochem. 2021;476:3537–3550.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen W, Lian J, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death Differ. 2020;27:695–710.
   PubMed Web of Science ®Google Scholar
• Liu D, Wang Y, Zhao Y, et al. SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis. BMC Cancer. 2020;20:178.
   PubMed Web of Science ®Google Scholar
• Xu W, Sun X, Zang C, et al. lncRNA SNHG7 promotes tumorigenesis of nasopharyngeal carcinoma via epithelial-to-mesenchymal transition. Oncol Lett. 2020;20:88.
   PubMed Web of Science ®Google Scholar
• Qiu M, Xu Y, Wang J, et al. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27. Cell Death Dis. 2015;6:e1858.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Zhang Y, Shen Z, et al. LncRNALUADT1 is overexpressed in colorectal cancer and its expression level is related to clinicopathology. Eur Rev Med Pharmacol Sci. 2018;22:2282–2286.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang F. Novel long noncoding RNA LINC01385 promotes nasopharyngeal carcinoma proliferation via the miR-140-3p/Twist1 signaling pathway. Cell Cycle. 2020;19:1352–1362.
   PubMed Web of Science ®Google Scholar
• Gao L, Wang S, Meng J, et al. LncRNA LUADT1 promotes oral squamous cell carcinoma cell proliferation by regulating miR-34a/GAS1 axis. Cancer Manag Res. 2020;12:3401–3407.
   PubMedGoogle Scholar
• Wang D, Wu W, Huang W, et al. LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer. BMC Pulm Med. 2019;19:246.
   PubMed Web of Science ®Google Scholar
• Song P, Yin SC. Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis. Gene. 2019;680:51–58.
   PubMed Web of Science ®Google Scholar
• Dong W, Dong Q, Ding H. Ophiopogonin B induces reactive oxygen species‑dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma. Mol Med Rep. 2021;24:534.
   PubMed Web of Science ®Google Scholar
• Oksuz DC, Prestwich RJ, Carey B, et al. Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy. Radiat Oncol. 2011;6:54.
   PubMed Web of Science ®Google Scholar
• Dechaphunkul T, Pruegsanusak K, Sangthawan D, et al. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol. 2011;3:30.
   PubMedGoogle Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Vance KW, Ponting CP. Transcriptional regulatory functions of nuclear long noncoding RNAs. Trends Genet. 2014;30:348–355.
   PubMed Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358–369.
   PubMed Web of Science ®Google Scholar
• Zhuang LK, Yang YT, Ma X, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203.
   PubMed Web of Science ®Google Scholar
• Liu F, Wei J, Hao Y, et al. Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase. Bioengineered. 2021;12:7119–7130.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang T, Zhang J, et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518–6530.
   PubMed Web of Science ®Google Scholar
• Ge X, Gong L. MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1. Tumour Biol. 2017;39:1010428317695947.
   Google Scholar
• Li X, Liu Y, Zhang C, et al. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway. Oncotarget. 2017;8:16356–16366.
   PubMedGoogle Scholar
• Sun X, Ren Z, Cun Y, et al. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. Nucleic Acids Res. 2020;48:7182–7196.
   PubMed Web of Science ®Google Scholar
• Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13:877–883.
   PubMed Web of Science ®Google Scholar
• Yin L, Li W, Xu A, et al. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. EBioMedicine. 2020;51:102596.
   PubMed Web of Science ®Google Scholar
• Chai J, Xu S, Guo F. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma. Biochem Biophys Res Commun. 2017;488:297–302.
   PubMed Web of Science ®Google Scholar
• Yimlamai D, Christodoulou C, Galli GG, et al. Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.
   PubMed Web of Science ®Google Scholar
• Xu CM, Liu WW, Liu CJ, et al. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer Gene Ther. 2013;20:453–460.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie C, Li Q, et al. Clinical and prognostic significance of Yes-associated protein in colorectal cancer. Tumour Biol. 2013;34:2169–2174.
   PubMedGoogle Scholar
• Han X, Fang Z, Wang H, et al. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494. Biochem Biophys Res Commun. 2016;480:675–681.
   PubMed Web of Science ®Google Scholar